Version 2.78

Description

Dabigatran (marketed as Pradaxa in Australia, Europe and USA, Pradax in Canada, and Prazaxa in Japan) is an anticoagulant from the class of the direct thrombin inhibitors. It is being studied for various clinical indications and in some cases it offers an alternative to warfarin as the preferred orally administered anticoagulant ("blood thinner") since it does not require frequent blood tests for international normalized ratio (INR) monitoring while offering similar results in terms of efficacy. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Wikipedia

Basic Part Properties

Part Display Name
Dabigatran
Part Type
Component (Describes the core component or analyte measured)
Created On
2011-09-30
Construct for LOINC Short Name
Dabigatran

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP135651-0
ConceptMap translate
https://fhir.loinc.org/ConceptMap/$translate?system=http://loinc.org&code=LP135651-0

Language Variants Get Info

Tag Language Translation
zh-CN Chinese (China) 达比加群
Synonyms: 达比加群酯;dabigatran etexilate;Pradaxa;抗凝药物;抗凝血剂;凝血酶抵制药
fr-CA French (Canada) Dabigatran
es-ES Spanish (Spain) Dabigatran
it-IT Italian (Italy) Dabigatran
tr-TR Turkish (Turkey) Dabigatran
ru-RU Russian (Russian Federation) Дабигатран
nl-NL Dutch (Netherlands) dabigatran